MOLLER-SAN PEDRO CLAUS JUAN (Chief Executive Officer) sold 7.6% of their position (50K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.56M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/4/2020ACC: 0001104659-20-132165
DirectorOfficer· Chief Executive Officer
Since Sep 2018
-50K
Net shares
Net seller
$2.56M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
50K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−40.73K
Price / share
$51.27
Trade value
$2.09M
% of position
6.2%
12/2/2020
657.30K→616.57K
Common Stock
Indirect
Shares
−9.27K
Price / share
$50.98
Trade value
$472.38K
% of position
1.5%
12/3/2020
616.57K→607.30K
Total
Net shares
−50K
Net value
-$2.56M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/2/2020 | S · Sale | −40.73K | $51.27 | $2.09M | 6.2% | 657.30K | 616.57K |
| Common Stock Indirect | 12/3/2020 | S · Sale | −9.27K | $50.98 | $472.38K | 1.5% | 616.57K | 607.30K |
| Total | −50K | -$2.56M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
DirectShares owned15.63K
Common Stock
IndirectShares owned1.90K
Total
15.63K direct·1.90K indirect17.52K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 15.63K | Direct |
| Common Stock | 1.90K | Indirect |
| Total | 17.52K | 15.63K direct·1.90K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported